Skip to main content

Table 1 Output of metrics describing characteristics of websites for regenerative medicine clinics in Tijuana and San Diego

From: Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study

Category Characteristic San Diego metrics Tijuana metrics
Online Communication and Partnership Profile Facebook presence 76.9% 65.5%
Twitter presence 43.5% 26.4%
Other online presence 63.9% 37.3%
Address provided 97.3% 88.2%
Phone number provided 99.3% 97.3%
Email provided 63.9% 68.2%
Contact form 95.9% 85.5%
Multiple clinics in area 27.9% 6.4%
Partners mentioned 2.0% 12.7%
Links to suppliers or other clinics 3.4% 10.9%
Language: English 95.2% 40.0%
Language: Spanish 0.0% 40.0%
Language: Both English and Spanish 4.8% 20.0%
Partner location: Mexico 0.0% 78.6%
Partner location: USA 100% 0.0%
Partner location: Mexico and USA 0.0% 1.0%
Partner location: Other 0.0% 2.0%
Claims to Scientific Legitimacy Affiliation with academia 7.5% 0.9%
Affiliation with hospital/medical center 12.9% 13.6%
Affiliation with society/network 27.9% 13.6%
Affiliation with other authority 2.0% 6.4%
Clinical trials conducted 5.4% 5.5%
License for regenerative medicine 0.0% 11.8%
Accreditation from professional org. 25.9% 20.9%
FDA Approval 7.5% 1.8%
COFEPRIS Approval 0.0% 12.7%
Patent pending 0.0% 0.0%
Patent approved 0.7% 0.9%
Evidence cited: any (including testimonials) 39.5% 33.6%
Evidence cited: peer-reviewed 9.5% 5.5%
Evidence cited: lay press/blogs 4.8% 3.6%
Evidence cited: self-publication 17.7% 6.4%
Intervention Details Number of diseases treated (mean) 6.04 8.15
Cost per Session $1523.04 $3691
PRP Offered 87.1% 67.3%
Follow-up Mentioned 6.1% 11.8%
Expectation: Unclear 17% 49.1%
Expectation: Improvement 76.9% 48.2%
Expectation: Cure 0.7% 0.0%
Risk: Not mentioned 41.5% 55.5%
Risk: Safe 51.0% 38.2%
Risk: Minor 5.4% 6.0%
Risk: Moderate 2.0% 0.0%
Risk: Major 0.0% 0.0%
Tissue origin: USA 84.4% 0.9%
Tissue origin: Mexico 0.0% 60.0%
Tissue origin: Unspecified 15.6% 39.1%
Tissue source: Autologous 84.4% 61.8%
Tissue source: Allogenic 13.6% 20.0%
Tissue source: Xenogenic 1.4% 1.8%
Tissue source: Unspecified 10.9% 32.7%
Cell type: Adult Stem Cells 21.8/% 29.1%
Cell type: Embryonic Stem Cells 0.0% 3.6%
Cell type: IPSC 0.0% 0.0%
Cell type: Cord, amniotic, or placental 13.6% 8.2%
Cell type: Unspecified 11.6% 26.4%
Route: Intrathecal 0.7% 8.2%
Route: Oral 0.0% 0.0%
Route: Topical 0.7% 0.9%
Route: Intravenous 6.8% 14.5%
Route: Intramuscular 0.7% 4.5%
Route: Other 82.3% 50.9%
Route: Unspecified 13.6% 42.7%